ORIC
Price
$11.47
Change
+$0.57 (+5.23%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
928.88M
28 days until earnings call
SLXN
Price
$0.82
Change
-$0.09 (-9.89%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
7.91M
Interact to see
Advertisement

ORIC vs SLXN

Header iconORIC vs SLXN Comparison
Open Charts ORIC vs SLXNBanner chart's image
Oric Pharmaceuticals
Price$11.47
Change+$0.57 (+5.23%)
Volume$38.62K
Capitalization928.88M
Silexion Therapeutics
Price$0.82
Change-$0.09 (-9.89%)
Volume$174
Capitalization7.91M
ORIC vs SLXN Comparison Chart in %
Loading...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORIC vs. SLXN commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORIC is a Hold and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ORIC: $11.45 vs. SLXN: $0.83)
Brand notoriety: ORIC and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORIC: 67% vs. SLXN: 80%
Market capitalization -- ORIC: $928.88M vs. SLXN: $7.91M
ORIC [@Biotechnology] is valued at $928.88M. SLXN’s [@Biotechnology] market capitalization is $7.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORIC’s FA Score shows that 0 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ORIC’s FA Score: 0 green, 5 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, ORIC is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORIC’s TA Score shows that 2 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ORIC’s TA Score: 2 bullish, 5 bearish.
  • SLXN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than ORIC.

Price Growth

ORIC (@Biotechnology) experienced а +6.02% price change this week, while SLXN (@Biotechnology) price change was +1.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

ORIC is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC($929M) has a higher market cap than SLXN($7.91M). ORIC YTD gains are higher at: 41.884 vs. SLXN (-58.910). SLXN has higher annual earnings (EBITDA): -16.96M vs. ORIC (-145.48M). ORIC has more cash in the bank: 204M vs. SLXN (6.15M). ORIC has less debt than SLXN: ORIC (3.21M) vs SLXN (3.48M). ORIC (0) and SLXN (0) have equivalent revenues.
ORICSLXNORIC / SLXN
Capitalization929M7.91M11,746%
EBITDA-145.48M-16.96M858%
Gain YTD41.884-58.910-71%
P/E RatioN/AN/A-
Revenue00-
Total Cash204M6.15M3,316%
Total Debt3.21M3.48M92%
TECHNICAL ANALYSIS
Technical Analysis
ORICSLXN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
60%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
41%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
23%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
25%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
26%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
48%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 4 days ago
51%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 24 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
20%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
61%
View a ticker or compare two or three
Interact to see
Advertisement
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USEMX23.64N/A
N/A
Victory Emerging Markets
GLPAX35.76N/A
N/A
Goldman Sachs MLP Energy Infras A
TRCPX23.90N/A
N/A
Nuveen Large Cap Value Premier
HNRIX29.13N/A
N/A
Hennessy Energy Transition Instl
LAMGX16.95N/A
N/A
Lord Abbett Micro Cap Growth A

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+5.05%
ERAS - ORIC
50%
Loosely correlated
-1.30%
ATXS - ORIC
48%
Loosely correlated
-1.48%
ROIV - ORIC
48%
Loosely correlated
+3.12%
KYMR - ORIC
48%
Loosely correlated
+0.07%
ETNB - ORIC
46%
Loosely correlated
+2.04%
More

SLXN and

Correlation & Price change

A.I.dvisor tells us that SLXN and QSI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLXN and QSI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLXN
1D Price
Change %
SLXN100%
-9.23%
QSI - SLXN
25%
Poorly correlated
-3.21%
CHRS - SLXN
24%
Poorly correlated
-0.12%
FBRX - SLXN
22%
Poorly correlated
-8.21%
ORIC - SLXN
20%
Poorly correlated
+5.05%
MTVA - SLXN
13%
Poorly correlated
+3.91%
More